Six hub genes, including BCL3, HCK, PPIF, S100A9, SERPINA1, and TBC1D9B that differentiated on admission after myocardial infarction the HF patients from the non-HF ones, can serve as early prognostic biomarkers of post-AMI patients. This evidence concerns the gene SERPINA1 and myocardial infarction.